REGEN
ToolsNotesBlogFAQ
← The board33/100 reports · early signal
Community read · grade S · Regulatory approval

Tesamorelin

An FDA-approved GHRH analog known for reducing stubborn visceral fat and raising IGF-1…

Built from 33 anonymous reports · a pattern, not a conclusion

The read

What people observed

Every report answers on a 1–5 scale. This is the whole distribution, never an average pretending to be one number, though the average is beside it.

n=33
1 · no effect
5
2 · barely
6
3 · modest
11
4 · clearly worked
4
5 · textbook
7
3.1/5
Average reported outcome
79%
Would run it again
33
Reports filed · early signal

What it did, and what else showed up

Counts across this compound's reports, never an average. One report can select several answers.

Reported positive outcomes

better sleep
5
fat loss
5
appetite suppression
5
faster recovery
5
joint / tendon relief
5
mood / focus
5
cognition
5
strength / pump
4
cardiovascular / circulation
4
more energy
3
libido
3
injury healing
3
skin / hair
2
better bloodwork
1

Reported side effects

Kept separate from positive outcomes on purpose.

heart rate
9
none / clean
8
mood / anxiety
7
headache
6
injection-site irritation
4
fatigue
4
GI / nausea
3
appetite change
3
sleep disruption
2

How it was run

What people brought it in for, and how long they stayed on it. Intent, not a result or a treatment claim.

What people were researching

sleep
4
energy / endurance
3
cardiovascular / blood pressure
3
recovery / injury
2
focus / cognition
2
appetite / weight
1
joint / tendon comfort
1
mood / anxiety
1
skin / hair
1
libido / sexual function
1
body composition
1
longevity / healthspan
1

How long they ran it

1 wk
3
2 wk
2
4 wk
6
6 wk
7
8 wk
6
12 wk
4
16 wk+
5
Safety

Anecdote, never medical advice.

These are anonymous personal reports on an experimental research compound, not clinical evidence, and they never set the grade. Talk to a licensed clinician before you start, stop, or change a dose.

Put the whole protocol
in one place.